Learning Curve for Transanal Total Mesorectal Excision for Low Rectal Malignancy
- PMID: 36735483
- DOI: 10.1097/XCS.0000000000000608
Learning Curve for Transanal Total Mesorectal Excision for Low Rectal Malignancy
Abstract
Background: Although transanal total mesorectal excision (TaTME) is a promising treatment for low rectal cancer, it is considered technically demanding, and the number of cases required to become proficient in TaTME remains unknown. The purpose of this study was to assess the TaTME learning curve based on the total mesorectal excision completion time.
Study design: This retrospective analysis comprised 128 individuals who received TaTME between September 2016 and December 2021. The cumulative sum method was used to generate the learning curve. The duration of the procedure from the beginning to the end of the circumferential rendezvous was used to define the total mesorectal excision completion time.
Results: The learning curve consists of 3 phases: phase I (learning phase: cases 1 to 38), phase II (consolidation phase: cases 39 to 70), and phase III (maturing phase: cases 71 to 128). As the phases varied, both the overall operative time and total mesorectal excision completion time decreased considerably. Through the 3 phases of TaTME, intraoperative adverse events decreased, and in phase III, none occurred. Only 1 instance of local recurrence occurred during phase III, and none occurred during phase I or II.
Conclusions: After 70 operations, the surgeon could join the mastery phase of TaTME based on the total mesorectal excision completion time. After the mastering phase began, there were no intraoperative negative occurrences. From the beginning, the oncological safety could be guaranteed.
Copyright © 2023 by the American College of Surgeons. Published by Wolters Kluwer Health, Inc. All rights reserved.
Comment in
-
Transanal Total Mesorectal Excision Learning Curve: How Should It Be?J Am Coll Surg. 2023 Aug 1;237(2):395-396. doi: 10.1097/XCS.0000000000000743. Epub 2023 May 9. J Am Coll Surg. 2023. PMID: 37158463 No abstract available.
-
The Essence of Transanal Total Mesorectal Excision: In Reply to Yuksel.J Am Coll Surg. 2023 Aug 1;237(2):396. doi: 10.1097/XCS.0000000000000751. Epub 2023 May 9. J Am Coll Surg. 2023. PMID: 37158472 No abstract available.
References
-
- Sylla P, Rattner DW, Delgado S, Lacy AM. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc. 2010;24:1205–1210.
-
- de Lacy AM, Rattner DW, Adelsdorfer C, et al. Transanal natural orifice transluminal endoscopic surgery (NOTES) rectal resection: “down-to-up” total mesorectal excision (TME)--short-term outcomes in the first 20 cases. Surg Endosc. 2013;27:3165–3172.
-
- Penna M, Hompes R, Arnold S, et al. Transanal total mesorectal excision: international registry results of the first 720 cases. Ann Surg. 2017;266:111–117.
-
- D’Andrea AP, McLemore EC, Bonaccorso A, et al. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve. Surg Endosc. 2020;34:4101–4109.
-
- Maykel JA, Hahn SJ, Beauharnais CC, et al. Oncologic outcomes after transanal total mesorectal excision for rectal cancer. Dis Colon Rectum. 2022;65:827–836.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
